↓ Skip to main content

Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts

Overview of attention for article published in BMC Cancer, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
Published in
BMC Cancer, September 2010
DOI 10.1186/1471-2407-10-515
Pubmed ID
Authors

Qing Chang, Mark S Chapman, Jeffrey N Miner, David W Hedley

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Uruguay 1 4%
Unknown 25 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 26%
Professor > Associate Professor 4 15%
Other 4 15%
Student > Ph. D. Student 3 11%
Student > Doctoral Student 3 11%
Other 4 15%
Unknown 2 7%
Readers by discipline Count As %
Medicine and Dentistry 8 30%
Agricultural and Biological Sciences 8 30%
Biochemistry, Genetics and Molecular Biology 4 15%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Social Sciences 1 4%
Other 2 7%
Unknown 2 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2021.
All research outputs
#3,784,244
of 18,758,139 outputs
Outputs from BMC Cancer
#934
of 6,799 outputs
Outputs of similar age
#71,882
of 276,028 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 18,758,139 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,799 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,028 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them